110 related articles for article (PubMed ID: 23833654)
1. Aberrant expression of the
Akazawa T; Yasui K; Gen Y; Yamada N; Tomie A; Dohi O; Mitsuyoshi H; Yagi N; Itoh Y; Naito Y; Yoshikawa T
Oncol Lett; 2013 Jun; 5(6):1849-1853. PubMed ID: 23833654
[TBL] [Abstract][Full Text] [Related]
2. A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis.
Zhang L; Huang Q; Lou J; Zou L; Wang Y; Zhang P; Yang G; Zhang J; Yu L; Yan D; Zhang C; Qiao J; Wang S; Wang S; Xu Y; Ji H; Chen Z; Zhang Z
Oncotarget; 2017 Mar; 8(12):19684-19698. PubMed ID: 28160558
[TBL] [Abstract][Full Text] [Related]
3. Depletion of PHF14, a novel histone-binding protein gene, causes neonatal lethality in mice due to respiratory failure.
Huang Q; Zhang L; Wang Y; Zhang C; Zhou S; Yang G; Li Z; Gao X; Chen Z; Zhang Z
Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):622-33. PubMed ID: 23688586
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive pan-cancer analysis unveiling the oncogenic effect of plant homeodomain finger protein 14 (PHF14) in human tumors.
Cao Z; Zhan H; Wu W; Kuang Z; Mo F; Liu X; Dai M
Front Genet; 2023; 14():1073138. PubMed ID: 37007943
[TBL] [Abstract][Full Text] [Related]
5. PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer.
Pan G; Zhang K; Geng S; Lan C; Hu X; Li C; Ji H; Li C; Hu X; Wang Y; Lv M; Cui H
Cancer Lett; 2022 Apr; 531():109-123. PubMed ID: 35074497
[TBL] [Abstract][Full Text] [Related]
6. Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway.
Wu S; Luo C; Li F; Hameed NUF; Jin Q; Zhang J
Cancer Cell Int; 2019; 19():314. PubMed ID: 31798343
[TBL] [Abstract][Full Text] [Related]
7. Pulsed SILAC-based proteomic analysis unveils hypoxia- and serum starvation-induced
Park JE; Tse SW; Xue G; Assisi C; Maqueda AS; Ramon GPX; Low JK; Kon OL; Tay CY; Tam JP; Sze SK
Oncotarget; 2019 Mar; 10(22):2136-2150. PubMed ID: 31040906
[TBL] [Abstract][Full Text] [Related]
8. PHF14 Promotes Cell Proliferation and Migration through the AKT and ERK1/2 Pathways in Gastric Cancer Cells.
Zhao Y; He J; Li Y; Xu M; Peng X; Mao J; Xu B; Cui H
Biomed Res Int; 2020; 2020():6507510. PubMed ID: 32596345
[TBL] [Abstract][Full Text] [Related]
9. The high mobility group protein HMG20A cooperates with the histone reader PHF14 to modulate TGFβ and Hippo pathways.
Gómez-Marín E; Posavec-Marjanović M; Zarzuela L; Basurto-Cayuela L; Guerrero-Martínez JA; Arribas G; Yerbes R; Ceballos-Chávez M; Rodríguez-Paredes M; Tomé M; Durán RV; Buschbeck M; Reyes JC
Nucleic Acids Res; 2022 Sep; 50(17):9838-9857. PubMed ID: 36124662
[TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib.
Zhang D; Yong W; Movassaghi M; Rodriguez FJ; Yang I; McKeever P; Qian J; Li JY; Mao Q; Newell KL; Green RM; Welsh CT; Heaney AP
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359362
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for bipartite recognition of histone H3 by the PZP domain of PHF14.
Zheng S; Bi Y; Chen H; Gong B; Jia S; Li H
Nucleic Acids Res; 2021 Sep; 49(15):8961-8973. PubMed ID: 34365506
[TBL] [Abstract][Full Text] [Related]
12. PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury.
Yang B; Chen S; Wu M; Zhang L; Ruan M; Chen X; Chen Z; Mei C; Mao Z
Sci Rep; 2017 Jan; 7():39888. PubMed ID: 28045076
[TBL] [Abstract][Full Text] [Related]
13. Phf14, a novel regulator of mesenchyme growth via platelet-derived growth factor (PDGF) receptor-α.
Kitagawa M; Takebe A; Ono Y; Imai T; Nakao K; Nishikawa S; Era T
J Biol Chem; 2012 Aug; 287(33):27983-96. PubMed ID: 22730381
[TBL] [Abstract][Full Text] [Related]
14. PHF14 is required for germinal center B cell development.
Zhang L; Lu Y; Wang Y; Wang F; Zhai S; Chen Z; Cai Z
Cell Immunol; 2020 Dec; 358():104221. PubMed ID: 33035772
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
[TBL] [Abstract][Full Text] [Related]
16. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
[TBL] [Abstract][Full Text] [Related]
18. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
20. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
Kitamura T; Srivastava J; DiGiovanni J; Kiguchi K
Mol Carcinog; 2015 Jun; 54(6):459-72. PubMed ID: 24839254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
